Published in Cell on August 09, 1991
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A (1995) 7.31
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A (1992) 4.13
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med (2002) 3.16
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A (1995) 3.06
The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol (1992) 2.76
Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A (1996) 2.75
Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet (1994) 2.65
In vivo cloning of PCR products in E. coli. Nucleic Acids Res (1993) 2.40
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest (1993) 2.29
ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A (1993) 2.19
Architecture of inherited susceptibility to common cancer. Nat Rev Cancer (2010) 2.14
Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol (1996) 1.94
Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.80
Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene (2001) 1.74
The ubiquitin system, disease, and drug discovery. BMC Biochem (2008) 1.73
Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet (1993) 1.72
Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc Natl Acad Sci U S A (1997) 1.72
Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett (2000) 1.70
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet (1993) 1.53
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J (1995) 1.48
Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol (1996) 1.47
Adenomatous polyposis coli on microtubule plus ends in cell extensions can promote microtubule net growth with or without EB1. Mol Biol Cell (2006) 1.42
Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation. BMC Genet (2016) 1.41
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer (2005) 1.40
Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet (1999) 1.39
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet (1995) 1.37
Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet (1992) 1.37
Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the beta-catenin destruction complex in polarized epithelial cells. J Cell Biol (2001) 1.36
Phenotypic, cytogenetic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet (1992) 1.32
The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A (2005) 1.32
Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. EMBO J (1992) 1.32
Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut (1995) 1.30
Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci U S A (2000) 1.29
APC and its modifiers in colon cancer. Adv Exp Med Biol (2009) 1.28
Mouse U2af1-rs1 is a neomorphic imprinted gene. Mol Cell Biol (1997) 1.27
Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am J Pathol (2008) 1.26
Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP) Am J Hum Genet (1993) 1.25
Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis. J Cell Biol (1997) 1.25
Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet (1996) 1.22
Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol (1996) 1.21
A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet (1993) 1.21
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am J Hum Genet (2000) 1.21
Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol (2001) 1.21
Establishment of a highly sensitive and specific exon-trapping system. Proc Natl Acad Sci U S A (1992) 1.17
Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J (2001) 1.17
Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. Am J Hum Genet (1993) 1.16
Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study. BMJ (1992) 1.14
Genetic mapping of the BRCA1 region on chromosome 17q21. Am J Hum Genet (1994) 1.13
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene. Proc Natl Acad Sci U S A (2001) 1.10
Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol (2013) 1.07
Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest (1994) 1.07
Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci U S A (1995) 1.04
Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer (1993) 1.04
Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2011) 1.03
Generation of mutant mice with large chromosomal deletion by use of irradiated ES cells--analysis of large deletion around hprt locus of ES cell. Mamm Genome (1998) 1.02
Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology (2004) 1.01
Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families. Mutat Res (2009) 1.00
Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br J Cancer (1993) 0.99
Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut (2001) 0.97
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut (1998) 0.95
p53 expression and K-ras mutation in colorectal adenomas. Gut (1993) 0.95
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer (2008) 0.95
Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis. Gut (1993) 0.93
APC mutation and the crypt cycle in murine and human intestine. Am J Pathol (1997) 0.92
Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines. J Clin Invest (1992) 0.92
Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci U S A (1997) 0.91
More than two decades of Apc modeling in rodents. Biochim Biophys Acta (2013) 0.91
SspI polymorphism in sequence encoding 3' untranslated region of the APC gene. Nucleic Acids Res (1991) 0.90
Pinin modulates expression of an intestinal homeobox gene, Cdx2, and plays an essential role for small intestinal morphogenesis. Dev Biol (2010) 0.89
Cortical localization of APC2 plays a role in actin organization but not in Wnt signaling in Drosophila. J Cell Sci (2011) 0.89
Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol (2006) 0.88
The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochem Funct (2012) 0.87
Germline Missense Changes in the APC Gene and Their Relationship to Disease. Hered Cancer Clin Pract (2004) 0.87
A new phenotypic manifestation of familial adenomatous polyposis. Fam Cancer (2011) 0.87
Dietary fat-influenced development of colon neoplasia in Apc Min mice exposed to benzo(a)pyrene. Toxicol Pathol (2009) 0.87
Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. Ann Surg (1999) 0.86
The mouse Clock locus: sequence and comparative analysis of 204 kb from mouse chromosome 5. Genome Res (2000) 0.86
Complementation of the beige mutation in cultured cells by episomally replicating murine yeast artificial chromosomes. Proc Natl Acad Sci U S A (1996) 0.86
From genotype to phenotype: genetics and medical practice in the new millennium. Philos Trans R Soc Lond B Biol Sci (1999) 0.85
Alpha-catenin is essential in intestinal adenoma formation. Proc Natl Acad Sci U S A (2007) 0.85
Presymptomatic diagnosis in families with adenomatous polyposis using highly polymorphic dinucleotide CA repeat markers flanking the APC gene. J Med Genet (1994) 0.85
Development and progression of colorectal neoplasia. Cancer Biomark (2010) 0.85
Rapid detection of rare variants and common polymorphisms in the APC gene by PCR-SSCP for presymptomatic diagnosis and showing allele loss. J Med Genet (1995) 0.84
Self-association of the APC tumor suppressor is required for the assembly, stability, and activity of the Wnt signaling destruction complex. Mol Biol Cell (2014) 0.84
Physical mapping of a 670-kb region of chromosomes XVI and XVII from the human protozoan parasite Trypanosoma cruzi encompassing the genes for two immunodominant antigens. Genome Res (1999) 0.84
Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut (1999) 0.84
Regulation of microtubule (MT)-based cytoskeleton in the seminiferous epithelium during spermatogenesis. Semin Cell Dev Biol (2016) 0.84
Extra-abdominal desmoid tumors associated with familial adenomatous polyposis. Sarcoma (2012) 0.83
Discovering tumor suppressor genes through genome-wide copy number analysis. Curr Genomics (2010) 0.83
Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol (2016) 0.82
The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv Exp Med Biol (2009) 0.82
Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain. Carcinogenesis (2012) 0.82
Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am J Pathol (1994) 0.82
Real time quantitative PCR. Genome Res (1996) 35.79
Two differentially regulated mRNAs with different 5' ends encode secreted with intracellular forms of yeast invertase. Cell (1982) 25.10
Identification and characterization of the familial adenomatous polyposis coli gene. Cell (1991) 14.46
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev (2001) 11.25
The Bloom's syndrome gene product is homologous to RecQ helicases. Cell (1995) 9.91
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
Ssn6-Tup1 is a general repressor of transcription in yeast. Cell (1992) 8.54
The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem (1998) 8.46
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell (1990) 8.10
A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science (1986) 7.73
Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet (1992) 6.97
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell (1990) 6.94
A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Hum Reprod (1998) 6.80
Sequence of chicken ovalbumin mRNA. Nature (1978) 6.73
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
Mutants of yeast defective in sucrose utilization. Genetics (1981) 6.20
Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae. Genetics (1984) 6.09
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell (1990) 5.24
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44
The prevalence of homelessness among adolescents in the United States. Am J Public Health (1998) 4.07
Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. Proc Natl Acad Sci U S A (1995) 4.06
The secreted form of invertase in Saccharomyces cerevisiae is synthesized from mRNA encoding a signal sequence. Mol Cell Biol (1983) 3.96
Alleles of the APC gene: an attenuated form of familial polyposis. Cell (1993) 3.84
Cloning and genetic mapping of SNF1, a gene required for expression of glucose-repressible genes in Saccharomyces cerevisiae. Mol Cell Biol (1984) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A suppressor of SNF1 mutations causes constitutive high-level invertase synthesis in yeast. Genetics (1984) 3.81
Another advanced test of theory of mind: evidence from very high functioning adults with autism or asperger syndrome. J Child Psychol Psychiatry (1997) 3.68
Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril (2000) 3.60
Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5. Am J Hum Genet (1988) 3.58
Molecular analysis of SSN6, a gene functionally related to the SNF1 protein kinase of Saccharomyces cerevisiae. Mol Cell Biol (1987) 3.57
Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. Proc Natl Acad Sci U S A (1991) 3.55
Surgery on the rheumatoid cervical spine for the non-ambulant myelopathic patient-too much, too late? Lancet (1996) 3.52
The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev (1993) 3.50
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell (2001) 3.34
A protein kinase substrate identified by the two-hybrid system. Science (1992) 3.34
Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem (2001) 3.31
Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20
Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem (1994) 3.18
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J (1995) 3.16
Molecular analysis of the SNF4 gene of Saccharomyces cerevisiae: evidence for physical association of the SNF4 protein with the SNF1 protein kinase. Mol Cell Biol (1989) 3.13
Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A (1994) 3.10
Upstream region required for regulated expression of the glucose-repressible SUC2 gene of Saccharomyces cerevisiae. Mol Cell Biol (1984) 3.06
Mutational analysis of the Saccharomyces cerevisiae SNF1 protein kinase and evidence for functional interaction with the SNF4 protein. Mol Cell Biol (1989) 3.06
Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev (2000) 3.05
Two homologous zinc finger genes identified by multicopy suppression in a SNF1 protein kinase mutant of Saccharomyces cerevisiae. Mol Cell Biol (1993) 3.00
The yeast SNF3 gene encodes a glucose transporter homologous to the mammalian protein. Proc Natl Acad Sci U S A (1988) 2.99
Glucose regulates protein interactions within the yeast SNF1 protein kinase complex. Genes Dev (1996) 2.97
Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology (1997) 2.96
Evolution of the dispersed SUC gene family of Saccharomyces by rearrangements of chromosome telomeres. Mol Cell Biol (1985) 2.88
The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes. Mol Cell Biol (1990) 2.87
Nucleotide sequence of the yeast SUC2 gene for invertase. Nucleic Acids Res (1983) 2.86
Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med (1992) 2.85
Blood-lead and hypertension. Lancet (1976) 2.82
An essential Saccharomyces cerevisiae gene homologous to SNF2 encodes a helicase-related protein in a new family. Mol Cell Biol (1992) 2.78
The SNF3 gene is required for high-affinity glucose transport in Saccharomyces cerevisiae. J Bacteriol (1987) 2.77
The problem-orientated medical record in general practice. J R Coll Gen Pract (1973) 2.77
Snf1 protein kinase regulates phosphorylation of the Mig1 repressor in Saccharomyces cerevisiae. Mol Cell Biol (1998) 2.69
Structure and expression of the SNF1 gene of Saccharomyces cerevisiae. Mol Cell Biol (1984) 2.69
A family of proteins containing a conserved domain that mediates interaction with the yeast SNF1 protein kinase complex. EMBO J (1994) 2.66
Mutations causing constitutive invertase synthesis in yeast: genetic interactions with snf mutations. Genetics (1987) 2.65
Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet (1994) 2.65
Suppressors of SNF2 mutations restore invertase derepression and cause temperature-sensitive lethality in yeast. Genetics (1986) 2.64
Upstream region of the SUC2 gene confers regulated expression to a heterologous gene in Saccharomyces cerevisiae. Mol Cell Biol (1985) 2.52
REG1 binds to protein phosphatase type 1 and regulates glucose repression in Saccharomyces cerevisiae. EMBO J (1995) 2.50
Organization of the SUC gene family in Saccharomyces. Mol Cell Biol (1983) 2.48
Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell (1991) 2.48
Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. Proc Natl Acad Sci U S A (1995) 2.48
The N-terminal TPR region is the functional domain of SSN6, a nuclear phosphoprotein of Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.47
Subcellular localization of the Snf1 kinase is regulated by specific beta subunits and a novel glucose signaling mechanism. Genes Dev (2001) 2.45
The Snf1 protein kinase and its activating subunit, Snf4, interact with distinct domains of the Sip1/Sip2/Gal83 component in the kinase complex. Mol Cell Biol (1997) 2.42
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
Yeast SNF2/SWI2, SNF5, and SNF6 proteins function coordinately with the gene-specific transcriptional activators GAL4 and Bicoid. Genes Dev (1992) 2.38
Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32
Null mutations in the SNF3 gene of Saccharomyces cerevisiae cause a different phenotype than do previously isolated missense mutations. Mol Cell Biol (1986) 2.30
TUP1 utilizes histone H3/H2B-specific HDA1 deacetylase to repress gene activity in yeast. Mol Cell (2001) 2.29
Glucose-regulated interaction of a regulatory subunit of protein phosphatase 1 with the Snf1 protein kinase in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1998) 2.29
Superglue inadvertently used as eyedrops. BMJ (1990) 2.17